AUVI-Q Drug Patent Profile
✉ Email this page to a colleague
When do Auvi-q patents expire, and what generic alternatives are available?
Auvi-q is a drug marketed by Kaleo Inc and is included in one NDA. There are eighteen patents protecting this drug.
This drug has one hundred and twelve patent family members in fourteen countries.
The generic ingredient in AUVI-Q is epinephrine. There are twenty-one drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the epinephrine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Auvi-q
A generic version of AUVI-Q was approved as epinephrine by BPI LABS on July 29th, 2014.
Summary for AUVI-Q
International Patents: | 112 |
US Patents: | 18 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 88 |
Patent Applications: | 4,301 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for AUVI-Q |
Drug Sales Revenues: | Drug sales revenues for AUVI-Q |
What excipients (inactive ingredients) are in AUVI-Q? | AUVI-Q excipients list |
DailyMed Link: | AUVI-Q at DailyMed |
Pharmacology for AUVI-Q
Drug Class | Catecholamine alpha-Adrenergic Agonist beta-Adrenergic Agonist |
Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for AUVI-Q
US Patents and Regulatory Information for AUVI-Q
AUVI-Q is protected by eighteen US patents.
Patents protecting AUVI-Q
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Medicament delivery device and methods for delivering drugs to infants and children
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHOD OF TREATING AN ALLERGIC REACTION USING AN AUTO-INJECTOR
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Medicament delivery device and methods for delivering drugs to infants and children
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHOD OF TREATING AN ALLERGIC REACTION USING AN AUTO-INJECTOR
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHOD OF TREATING AN ALLERGIC REACTION USING AN AUTO-INJECTOR
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Medicament delivery device configured to produce an audible output
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Medical injector with compliance tracking and monitoring
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Medicament delivery device having an electronic circuit system
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Devices, systems, and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHOD TO TREAT SEVERE ALLERGIC EMERGENCIES IN PATIENTS WEIGHING 7.5 TO 15 KG (16.5 TO 33 LBS)
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kaleo Inc | AUVI-Q | epinephrine | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 201739-001 | Aug 10, 2012 | BX | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
Kaleo Inc | AUVI-Q | epinephrine | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 201739-002 | Aug 10, 2012 | BX | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
Kaleo Inc | AUVI-Q | epinephrine | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 201739-001 | Aug 10, 2012 | BX | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for AUVI-Q
See the table below for patents covering AUVI-Q around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Mexico | 2010012334 | DISPOSITIVO DE ADMINISTRACION DE MEDICAMENTOS PROVISTO DE UN SISTEMA DE CIRCUITOS ELECTRONICOS. (MEDICAMENT DELIVERY DEVICE HAVING AN ELECTRONIC CIRCUIT SYSTEM.) | ⤷ Try a Trial |
United Kingdom | 201213906 | ⤷ Try a Trial | |
World Intellectual Property Organization (WIPO) | 2008091838 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |